LDH LD2812

GUDID 05055273204100

The LDH method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of lactate d

RANDOX LABORATORIES LIMITED

Total lactate dehydrogenase (LDH) IVD, reagent
Primary Device ID05055273204100
NIH Device Record Keyd8327e6e-f462-44bc-b2c4-de0c680655fd
Commercial Distribution StatusIn Commercial Distribution
Brand NameLDH
Version Model NumberLD2812
Catalog NumberLD2812
Company DUNS227530649
Company NameRANDOX LABORATORIES LIMITED
Device Count1
DM Exemptfalse
Pre-market Exemptfalse
MRI Safety StatusLabeling does not contain MRI Safety Information
Human Cell/Tissue Productfalse
Device Kittrue
Device Combination Productfalse
Single Usetrue
Lot Batchtrue
Serial Numberfalse
Manufacturing Datefalse
Expiration Datetrue
Donation Id Numberfalse
Contains Natural Rubber Latexfalse
Labeled No Natural Rubber Latexfalse
RX Perscriptiontrue
OTC Over-The-Counterfalse

Customer Support Contacts

Phone+442894451070
Emailtechnical.services@randox.com

Operating and Storage Conditions

Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius

Device Identifiers

Device Issuing AgencyDevice ID
GS105055273204100 [Primary]

FDA Pre-market Approvals/Notifications & deNovo

FDA Product Code

CFJNad Reduction/Nadh Oxidation, Lactate Dehydrogenase

Sterilization

Steralize Prior To Usefalse
Device Is Sterilefalse

Device Entry Metadata

Public Version StatusUpdate
Device Record StatusPublished
Public Version Number3
Public Version Date2018-07-06
Device Publish Date2016-09-24

Devices Manufactured by RANDOX LABORATORIES LIMITED

05055273210101 - Liquid Immunoassay Control – Level 1 (IA CONTROL 1)2025-04-01 The Liquid Immunoassay Control is intended for use with in vitro diagnostic assays for the quantitative determination of 25-OH V
05055273210118 - LIQUID IMMUNOASSAY CONTROL - LEVEL 2 (IA CONTROL 2)2025-04-01 The Liquid Immunoassay Control is intended for use with in vitro diagnostic assays for the quantitative determination of 25-OH V
05055273210125 - LIQUID IMMUNOASSAY CONTROL - LEVEL 3 (IA CONTROL 3)2025-04-01 The Liquid Immunoassay Control is intended for use with in vitro diagnostic assays for the quantitative determination of 25-OH V
05055273219814 - PTH CONTROL LEVEL 1 (PTH CONTROL 1)2025-04-01 The PTH Control Level 1 is intended for use with in vitro diagnostic immunoassays for the quantitative determination of Parathyr
05055273219821 - PTH CONTROL LEVEL 2 (PTH CONTROL 2)2025-04-01 The PTH Control Level 2 is intended for use with in vitro diagnostic immunoassays for the quantitative determination of Parathyr
05055273219838 - PTH CONTROL LEVEL 3 (PTH CONTROL 3)2025-04-01 The PTH Control Level 3 is intended for use with in vitro diagnostic immunoassays for the quantitative determination of Parathyr
05055273219043 - LIQUID CARDIAC CONTROL 12025-03-31 The Liquid Cardiac Controls are intended for use with in vitro diagnostic assays for the quantitative determination of CKMB, Hig
05055273219050 - LIQUID CARDIAC CONTROL 22025-03-31 The Liquid Cardiac Controls are intended for use with in vitro diagnostic assays for the quantitative determination of CKMB, Hig

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.